Introduction

CD40 is a member of the tumor necrosis factor (TNF)
B cells (8,9). In monocytes/macrophages, CD40 engagement induces the production of pro-inflammatory cytokines and receptor superfamily and is expressed on numerous cell types, including B cells, macrophages/monocytes, endochemokines such as IL-1α/β, IL-6, IL-8, IL-10, IL-12, TNF-α and MIP-1α (10,11). Signaling through CD40 in monocytes/ thelial cells, dendritic cells, fibroblasts and vascular smooth muscle cells (1-3). The ligand for CD40, CD154, is transiently macrophages also results in up-regulation of co-stimulatory molecules (11), nitric oxide generation (12), rescue from expressed on activated T cells (4), and has been found on platelets and mast cells (5,6). Functional outcomes of CD40 apoptosis (11) and induction of metalloproteinase production (13). The importance of CD40-dependent macrophage activaligation have been most thoroughly studied in B cells, where CD40 engagement induces proliferation, differentiation, tion in host defense is supported by the finding that CD154 knockout mice have defective macrophage effector function expression of co-stimulatory molecules and rescue from apoptosis (2,3,7). Signals through CD40 play an essential (14) . Signaling through CD40 is mediated in part by members role in T cell-dependent class switching and Ig production by of the TNF receptor-associated factor (TRAF) family of signal inflammatory cytokines, TNF-α, IL-6 and IL-8. These results suggest that CD40-mediated signaling activates distinct sets transduction proteins (15) (16) (17) (18) (19) (20) that are recruited to the CD40 cytoplasmic domain following ligand-induced receptor multiof MAPK pathways in monocytic cells and B cells. merization. Previous reports have demonstrated that the CD40 cytoplasmic domain associates directly with TRAF1, TRAF2, TRAF3 and TRAF6 (15) (16) (17) (18) (19) 21) , and recruits TRAF5 as a Methods TRAF3/5 hetero-oligomer (21) . It has been shown that overexpression of either TRAF2, TRAF5, TRAF6 or a splice variant Reagents of TRAF3 can activate NF-κB, whereas TRAF2 and TRAF6
Polyclonal antibodies specific for phospho-MEK1/2, MEK1/2 are involved in activating the c-Jun N-terminal kinase (JNK) or phospho-c-Myc and the MEK inhibitor PD98059 were signaling pathway (22) (23) (24) (25) (26) (27) ). TRAF6 appears to be capable from New England Biolabs (Beverly, MA). PD98059 was of activating signaling through the two additional mitogendissolved in tissue culture grade DMSO (Sigma, St Louis, activated protein kinase (MAPK) pathways, extracellular sig-MO) at a stock concentration of 25 mM and stored at -20°C. nal-regulated kinases (ERK) 1/2 and p38 MAPK (28, 29) .
Anti-mouse CD8α (53-6.6), human recombinant IFN-γ and Although no direct signaling role has been established for human recombinant granulocyte macrophage colony TRAF1, cells from TRAF1 transgenic mice are more resistant stimulating factor were obtained from PharMingen (San to TNF-induced apoptosis, and a possible role for TRAF1 in Diego, CA). GST-c-Jun was from Stratagene (La Jolla, CA). regulating apoptosis, has been proposed (30) .
Polyclonal antibodies recognizing TRAF2, TRAF3, TRAF6 or Signals generated as a result of CD40 ligation in B cells JNK1(FL) and anti-JNK(FL)-agarose were from Santa Cruz have been demonstrated to activate the transcription factors Biotechnology (Santa Cruz, CA). Anti-active JNK and MAPK NF-κB, AP-1 and NF-AT that have been shown to play antibodies were from Promega (Madison, WI). Anti-ERK1/2 important roles in B cell responses (31) (32) (33) . Additionally, the antibody was from Transduction Laboratories (Lexington, KY). JNK1/2 and p38 MAPK pathways have been shown to be FCS (Defined) was from Hyclone (Logan, UT). ImmunoPure highly activated following CD40 ligation in B cells (34) (35) (36) (37) (38) (39) (40) .
Gentle Ag/Ab Elution Buffer, SuperSignal West Femto Max-CD40-dependent activation of the third MAPK pathway, imum Sensitivity Chemiluminescence substrate, 10% NP-40 ERK1/2, has been found in some normal mouse B cell systems and 10% Tween 20 were purchased from Pierce (Rockford, (35, 41) but not in human B cells or B cell lines (37, 38, 41 Science Products (Boston, MA). acetate (PMA)-and ionomycin-activated T cells induced a CD40-dependent phosphorylation/activation of ERK1/2 leadCells and cell culture ing to IL-1β and TNF-α synthesis (42) . Unlike soluble stimuli used for typical signaling studies, the T cell membranes used
The human promonocytic leukemia cell line, THP1 (43), was obtained from ATCC (Manassas, VA), and was cultured in in this system minimally diffuse, producing an asynchronous cellular stimulus. This necessitated the use of long time RPMI 1640 supplemented with 10% FCS, 50 µM 2-mercaptoethanol and 2 mM L-glutamine. Normal human monocytes courses to show increases and decreases in ERK1/2 phosphorylation (42) , making the results more qualitative.
were prepared from healthy donors by isolating peripheral blood mononuclear cells (PBMC) using Ficoll-Hypaque The outcomes of direct CD154-induced activation of signaling pathways in monocytic cells have not been studied. Additiondensity-gradient centrifugation. Monocytes were enriched by centrifugal elutriation (44) and cultured at 1-2ϫ10 6 cells/ml ally, endogenous TRAF expression has not been profiled in monocytic cells. Since TRAFs that mediate signaling through in RPMI 1640 supplemented with 10% FCS, 10 mM HEPES (pH 7.3), 2 mM L-glutamine, 0.1 mM non-essential amino CD40 appear to activate different sets of signaling pathways (16, 17, 20, 28) it might be expected that some cell-type acids, 1 mM sodium pyruvate, 50 µM 2-mercaptoethanol, 2 µg/ml polymyxin B sulfate and 50 µg/ml gentamicin sulfate. specificity in CD40 signaling could result from differential and regulated expression of TRAF proteins. In this study we have Monocytes isolated by this method were ജ90% pure as characterized by CD14 expression assessed by flow examined MAPK pathways activated by CD40 engagement with CD154 in normal human monocytes and in the human cytometry. To induce high levels of CD40 expression, isolated monocytes were incubated for 18 h with 5 ng/ml IFN-γ monocytic cell line, THP1. In normal monocytes and THP1 cells CD40 ligation activated ERK1/2 and JNK1 but not p38 prior to stimulation (11, 45) . For signaling studies cells were stimulated by addition of affinity-purified recombinant soluble MAPK, and resulted in significant up-regulation of TRAF1 mRNA. CD40 ligation was linked to activation of the ERK1/ mouse CD8α-human CD154 (soluble CD154) produced in Sf21 insect cells (28) . For cytokine secretion, cells were 2 pathway through its upstream activation kinase, MAPK kinase (MEK)1/2. The ERK1/2 pathway was shown to be stimulated with insect cell membranes containing full-length human CD154 (46) . Cells were cultured in 5.5% CO 2 at 37°C. directly involved in the CD40-mediated secretion of the pro- Reactions were terminated by the addition of 25 µl 2ϫSDS 260 nm and 10-30 µg was dried by vacuum centrifugation sample buffer, heated at 95°C for 5 min and proteins resolved for 1 h. Levels of mRNA transcripts were quantitated using by SDS-PAGE (12 or 14% polyacrylamide). Gels were dried a RiboQuant Multiprobe RNase Protection Assay System and labeled GST-c-Jun substrate detected by autoradio-(PharMingen) according to the manufacturer's instructions. A graphy or phosphorimaging. Radioactivity incorporated into custom-made template set consisting of TRAF1, TRAF2, GST-c-Jun substrate was quantitated using an AlphaImager TRAF3, TRAF4, TRAF5, TRAF6, and the L32 and GAPDH 2000 digital imaging analyzer. housekeeping genes was used. 33 P-labeled protected fragments were resolved by electrophoresis on 6% polyacrylCytokine assays amide TBE-urea gels. Gels were dried and radioactivity Monocytes (2ϫ10 6 /ml ) or THP1 cells (1ϫ10 6 /ml ) were visualized by a PhosphoImager (Molecular Dynamics, cultured with or without CD154 in insect membranes (46) Sunnyvale, CA) or exposure to X-ray film at -80°C.
for either 16 (monocytes) or 24 (THP1 cells) h at 37°C. Supernatants were collected and analyzed for the presence Immunoblot analyses of IL-1β, TNF-α, IL-6 and IL-8 using ELISA kits according to THP1 cells (1-5ϫ10 6 cells/ml) or monocytes (2-5ϫ10 6 cells/ the manufacturer's instructions. In some assays, cells were ml) were treated with appropriate stimuli for the indicated pretreated with various concentrations of the MEK1/2 inhibitor, times at 37°C. Cells were harvested by centrifugation (30 s, PD98059, or DMSO 1 h prior to the addition of CD154. No 13,000 g, 4°C). For whole-cell lysates, cell pellets were compound cytotoxicity was observed at 100 µM PD98059. resuspended in SDS sample buffer (2.5ϫ10 7 cells/ml).
The cytokine ELISA limits of detection were: IL-1β, 1 pg/ml; Alternatively, cells were lysed on ice for 30 min with modified TNF-α, 5 pg/ml; IL-6, 1 pg/ml; and IL-8, 2 pg/ml. RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% Nadeoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, 1 mM Peflabloc, 1 mM Na 3 VO 4, 1 mM NaF, 1 µg/ml aprotinin, 1 µg/ml Results leupeptin and 1 µg/ml pepstatin) and the lysates centrifuged (10 min, 13,000 g, 4°C). Clarified lysates were denatured in Constitutive and CD40-inducible TRAF mRNA expression in an equal volume of 2ϫSDS sample buffer. Proteins were human monocytes and human THP1 cells resolved by SDS-PAGE, and electrotransferred to nitrocelluInitiation of CD40 signaling events in B cells is primarily lose membranes in 25 mM Tris, pH 8.5, 0.2 M glycine and mediated by recruitment of TRAF protein family members to 20% methanol at 100 V for 1 h. Membranes were blocked for the CD40 cytoplasmic domain. In B cells, levels of TRAF1 1 h at room temperature or overnight in 1ϫTBST (Tris-buffered and TRAF4 mRNAs have been found to be up-regulated by saline containing 0.05% Tween 20) plus 2% BSA or 5% nonsignaling through CD40 (40) . In monocytic cells, the repertoire fat dry milk at 4°C and incubated with the appropriate antibody of TRAF mRNA and protein expression is not known. To diluted in 1ϫTBST plus 1 or 0.1% BSA for 2-3 h at room investigate expression of TRAF mRNAs in CD40 ϩ human temperature. Membranes were washed 3 times (10 min each) monocytes and THP1 cells, an RNase protection assay was in TBST, incubated with Protein G-horseradish peroxidase used with a custom multiprobe template set for the detection (1:4000) or Protein A-horseradish peroxidase (1:10,000) for of TRAF1, TRAF2, TRAF3, TRAF4, TRAF5 and TRAF6. The 1 h at room temperature and washed 4 times as above.
L32 and GAPDH housekeeping genes were included for Membranes were incubated in chemiluminescence detection comparative analysis of mRNA levels among samples. reagent for 5 min, and exposed to X-ray film for between 1 s Constitutive low expression of all six TRAF mRNAs was and 2 min at room temperature. To reprobe immunoblot found in unstimulated peripheral blood monocytes (Fig. 1A) . membranes with a different antibody, the membrane was Stimulation of monocytes with soluble CD154 for 18 h resulted stripped by incubation with ImmunoPure Gentle Ag/Ab Elution in a significant up-regulation of TRAF1 mRNA with a small Buffer (Pierce) for 2 h at room temperature or with Restore increase in mRNA levels of the other TRAFs relative to the Western Blot Stripping Buffer (Pierce) for 15 min at room L32 and GAPDH control mRNAs. In unstimulated THP1 cells temperature, washed with TBST, reblocked, reprobed and TRAF2, TRAF3, TRAF4 and TRAF6 mRNAs were constitutively redetected. Intensities of the protein bands were determined expressed. Stimulation of THP1 cells with soluble CD154 for from the films using an AlphaImager 2000 digital imaging various times showed that TRAF1 mRNA was weakly induced analyzer (Alpha Innotech, San Leandro, CA) in scan mode.
by 8 h, and a strong induction of TRAF1 mRNA expression was evident by 18 h (Fig. 1B) . TRAF5 mRNA expression was Determination of JNK activity also induced by CD40 ligation in THP1 cells after 18 h. TRAF5 mRNA induction was significantly weaker than TRAF1 mRNA THP1 cells (5ϫ10 6 cells/sample) stimulated with or without soluble CD154 were lysed as described above in 0.5 ml induction (Fig. 1B) .
To examine whether the constitutive TRAF mRNA expression modified RIPA buffer. Clarified cell lysates were added to 20 µl JNK1(FL) antibody-agarose suspension and incubated in monocytic cells corresponded to the expression of TRAF protein, the presence of TRAF2, TRAF3 and TRAF6 proteins with constant rotation for 2 h at 4°C. The agarose beads dually phosphorylated active ERK1/2 (top panel) or antibody to total with IFN-γ (5 ng/ml) followed by stimulation for the times indicated ERK MAPK (bottom panel) after stripping the immunoblot. (B) Serumwith soluble CD154 (10 µg/ml) at 37°C. RNAs were isolated and starved THP1 cells (5ϫ10 6 ) were stimulated for the times indicated analyzed [30 µg from peripheral blood monocytes (A) and 10 µg with soluble CD154 (10 µg/ml) and anti-CD8α (15 µg/ml) at 37°C. from THP1 cells (B)] with a multiprobe template set to detect TRAF1 Cell lysates were analyzed by immunoblotting with either antibody to to TRAF6 and two internal control mRNAs, L32 and GAPDH, as dually phosphorylated ERK (top panel) or antibody to total ERK described in Methods. 33 P-labeled protected fragments were resolved (bottom panel) after stripping the immunoblot. Data for each panel by electrophoresis on 6% polyacrylamide Novex TBE-urea gels and are representative of three independent experiments. visualized by PhosphoImaging. Positions of individual protected probe fragments for each mRNA species are indicated. A CD40-induced protected fragment migrating slightly faster than the protected probe for TRAF3 was also observed in most experiments experiments reveal both constitutive and CD40-regulated We investigated which of the three MAPK pathways, ERK, JNK are: TRAF2, 54,000; TRAF3, 63,000; and TRAF6, 59,000. or p38 MAPK, could be activated during CD154 treatment of human monocytes or THP1 cells. Activation of ERK1 and ERK2 was examined by detecting the appearance of dually phosphorylated (Thr202/Tyr204) ERK1 and/or ERK2. Cells were stimulated with soluble CD154 for various times, lysed was analyzed by immunoblotting. These TRAF proteins have been shown to play a major role in activating various CD40-and the lysate subjected to immunoblot analysis for activated ERK1/2. CD40 ligation resulted in a rapid and time-dependent dependent signaling pathways (22) (23) (24) (25) (26) (27) (28) (29) . In whole-cell lysates from unstimulated THP1 cells, TRAF2, TRAF3 and TRAF6 activation of ERK1/2 in monocytes ( Fig. 2A) and in THP1 cells (Fig. 2B) . The ERK2 protein appeared the most highly proteins were each readily detected (Fig. 1C) . In unstimulated peripheral blood monocytes TRAF6 and TRAF3 proteins were phosphorylated in both cell types. In THP1 cells, ERK1/2 activation was detectable as early as 30 s after CD40 ligation detected by immunoblot analysis (data not shown). TRAF2 protein could not be detected in unstimulated purified monoand was maximal at 3 min after CD40 ligation with~5-fold increase relative to unstimulated cells (Fig. 2B) . In monocytes, cytes. These results in conjunction with RNase protection ERK1/2 activation increased by 4-to 6-fold relative to unstimulated cells and was maximal by 12 min ( Fig. 2A and data not shown). In both monocytes and THP1 cells, ERK2 activation decreased after longer times of stimulation. In monocytes, ERK2 activation was still evident after 25 min of stimulation, presumably resulting from slower diffusion of soluble CD154 into pre-existing cellular clusters. Immunoblot analysis with an antibody that detected total ERK showed equivalent levels of ERK2 expression in all samples (Fig. 2) .
Activation of the JNK1 and JNK2 MAPK was also assessed after CD154 treatment of monocytes and THP1 cells. At various times after CD40 ligation cell lysates were subjected to immunoblot analysis with an antibody that detected dually phosphorylated JNK1/2. In both monocytes and THP1 cells stimulated with soluble CD154, a weak transient phosphorylation of JNK1 was observed (Fig. 3A and B) . In THP1 cells, JNK1 phosphorylation was maximal at 5 min (2.9-fold increase relative to unstimulated cells) and decreased after 10 min of stimulation (Fig. 3B) . In monocytes, JNK1 phosphorylation increased~2-fold and was maximal by 12 min (Fig. 3A and data not shown). Immunoblot analysis with an antibody that detected total JNK confirmed equivalent amounts of JNK1 in the lanes of Fig. 3A and B. JNK activity in CD154-stimulated THP1 cells was confirmed in an in vitro kinase assay using GST-c-Jun as a phosphorylation substrate for immunoprecipitated active JNK. CD40 ligation in THP1 cells induced a transient increase in JNK kinase activity that was maximal by 10 min with~20-fold increase relative to unstimulated cells (Fig. 3C) .
Activation of p38 MAPK following CD40 signaling in human monocytes or THP1 cells was assessed by immunoblot analysis with an antibody that detected dually phosphorylated activated p38 MAPK. No increase in phosphorylation of p38 MAPK was detected in either cell type after stimulation with soluble CD154 (data not shown). This was in contrast to the strong p38 MAPK activation found after lipopolysaccharide (LPS) or TNF-α stimulation of human monocytes or THP1 cells the CD40-stimulated ERK1/2 signaling pathway in monocytic cells, the involvement of the upstream ERK1/2 regulator, MEK1, was investigated. Monocytes and THP1 cells were stimulated for various times with soluble CD154 and cell
To further establish that CD40-stimulated MEK1 phosphorylation plays a role in activating ERK1/2, a MEK-specific lysates were examined by immunoblot analysis for the presence of active phosphorylated MEK1. In monocytes inhibitor, PD98059, was tested for its effects on CD40-dependent ERK1/2 phosphorylation. Various concentrations of phosphorylated MEK1 was increased by 3 min after CD154 stimulation (2.9-fold increase relative to unstimulated cells) PD98059 were preincubated with monocytes or THP1 cells for 1 h prior to stimulation with soluble CD154 for 10 min (Fig. 4A) . In THP1 cells phosphorylated MEK1 was significantly increased as early as 1 min after CD154 stimulation with and ERK1/2 phosphorylation was monitored after cell lysis. PD98059 strongly inhibited CD40-dependent ERK1/2 maximal levels of activated MEK1 found after 5-10 min of stimulation (~15-fold increase over unstimulated cells) (Fig. phosphorylation in a dose-dependent manner with complete inhibition of ERK1/2 activation at 50 µM PD98059 for mono-4C). Equivalent amounts of total MEK1 were confirmed in the lanes by immunoblot analysis with an antibody that detected cytes and 20 µM PD98059 for THP1 cells (Fig. 4B and D) . These results suggest an upstream role for MEK-mediated total MEK1 (Fig. 4A and C) . phorylating transcription factors such as c-Myc (48) . After stimulation of human monocytes for different times with soluble CD154, cell lysates were subjected to immunoblot analysis for phosphorylated c-Myc. Phosphorylation of c-Myc was undetectable in unstimulated cells and was induced as early as 1 min after CD154 stimulation (~50-fold increase relative to unstimulated cells). Levels of phosphorylated c-Myc were maintained and gradually decreased over 60 min (~20-fold increase relative to unstimulated cells at 60 min) (Fig. 5) . Inhibition of CD154-dependent c-Myc phosphorylation in monocytes by the MEK inhibitor, PD98059, was not observed (data not shown). In THP1 cells a 2-fold increase in phosphorylation of c-Myc was induced by CD154 stimulation. However, the background levels of c-Myc phosphorylation in unstimulated THP1 cells were high (data not shown) and it was not possible to perform experiments in the presence have suggested that CD40-dependent monocyte secretion of IL-1β and TNF-α is linked to activation of the ERK signaling pathway (42) . To establish whether CD40-dependent secretion of other pro-inflammatory cytokines could be linked to activation of the ERK1/2 pathway, normal peripheral blood ERK1/2 phosphorylation following CD154 stimulation of monocytic cells.
monocytes and THP1 cells were incubated with or without various concentrations of the MEK inhibitor, PD98059, for 1 h
CD40-dependent phosphorylation of c-Myc in monocytic cells
prior to stimulation with membrane CD154. Levels of TNF-α, IL-6 and IL-8 were quantitated in culture supernatants. CD40 To further map the CD40-stimulated ERK1/2 signaling pathway, activation of a downstream substrate of ERK was engagement with membrane CD154 induced secretion of all three pro-inflammatory cytokines from normal monocytes and examined. Activated ERK1 and ERK2 have the ability to translocate to the nucleus and activate transcription by phos-THP1 cells (Fig. 6) . Levels of secreted TNF-α, IL-6 and IL-8 were similar in monocytes and THP1 cells. As reported TRAF5 mRNA expression (Fig. 7) . This experiment additionally confirmed that CD40 stimulation with either soluble CD154 or previously, PD98059 blocked CD40-dependent secretion of TNF-α by monocytes and THP1 cells in a dose-dependent membrane CD154 gave similar high-level induction of TRAF1 mRNA and low-level induction of TRAF5 mRNA in THP1 cells. manner (Fig. 6) . Additionally, secretion of IL-6 and IL-8 by THP1 cells was blocked to background levels by PD98059 Thus, activation of the ERK1/2 pathway does not appear to be involved in CD40-mediated up-regulation of TRAF1 and concentrations (20 µM) that had been found to completely inhibit ERK1/2 phosphorylation (Fig. 6B) . Similar results were TRAF5 mRNAs. obtained for inhibition of IL-1β secretion by THP1 cells (data not shown). Secretion of TNF-α, IL-6 and IL-8 by monocytes Discussion was also inhibited to near background levels by 50 µM PD98059, the concentration found to completely inhibit
In mammalian cells at least three MAPK pathways have been identified, the classical MAPKs, ERK1 and ERK2, and the CD154-stimulated ERK1/2 phosphorylation (Fig. 6A) . Cytokine secretion by THP1 cells appeared several-fold more sensitive more recently described JNK1/JNK2 and p38 MAPK pathways. Various cell growth and differentiation stimuli have been than cytokine secretion by normal monocytes to inhibition by PD98059 (Fig. 6) . Thus, CD40 signaling in monocytic cells shown to activate the ERK1/2 pathway, leading to proliferation, differentiation and developmental responses (49) . The JNK1/2 resulted in activation of the ERK MAP kinases that appear to be directly linked to the secretion of TNF-α, IL-6, IL-8 and IL-1β. and p38 MAPK pathways are primarily activated by inflammatory cytokines and environmental stress and lead to CD40-dependent induction of TRAF1 or TRAF5 mRNA expresinflammatory, apoptotic or developmental responses (49) . The sion is not linked to ERK activation JNK1/2 cascade has been shown to be a primary pathway activated following stimulation of B cells and B cell lines To examine whether CD40-dependent up-regulation of TRAF1 and TRAF5 mRNAs shown in Fig. 1 was potentially linked to through CD40 (36) (37) (38) . In B cells, p38 MAPK is also activated through CD40 (36, 39, 40) , and appears to play an important activation of ERK1/2, RNA was isolated from THP1 cells that had been treated for 24 h with membrane CD154 and role in CD40-regulated gene expression and proliferation (40) . CD40-dependent ERK activation has not been found in normal PD98059. Levels of each of the TRAF mRNAs were evaluated by RNase protection assay. The MEK inhibitor PD98059 had human B cells, human B cell lines or mouse B cell lines (36) (37) (38) 41 ), but was found in studies on normal mouse splenic B no effect on the CD154-induced increases in TRAF1 or Previous studies in monocytes had linked T cell-and CD40-dependent secretion of the pro-inflammatory cytokines, IL-1β and TNF-α, to activation of the ERK1/2 pathway (42), and we have confirmed these findings. We additionally provide evidence that CD40-dependent secretion of the pro-inflammatory cytokines, IL-6 and IL-8, was linked to activation of ERK1/2. Taken together these results suggest that CD40-dependent activation of the ERK1/2 pathway in monocytic cells plays a central role in the secretion of proinflammatory cytokines. Involvement of the ERK pathway in up-regulation of co-stimulatory molecules, nitric oxide generation or metalloproteinase production remains to be determined.
We obtained a low but consistent CD40-dependent activation of the JNK pathway in peripheral blood monocytes and THP1 cells. It remains to be determined whether higher levels of JNK pathway activation would result from CD40 engagement in normal mature macrophage effector cells.
In normal monocytes and THP1 monocytic cells we found no CD40-dependent p38 MAPK activation. Both of these monocyte systems showed strong p38 MAPK activation in response to LPS or TNF-α, confirming that the lack of p38 MAPK activation was specific to signals delivered through the CD40 receptor. We have previously demonstrated activation (28) . In this system TRAF6 was found to play membrane CD154 (10 µg/ml) or medium for 24 h. RNAs were isolated an important role in CD40-mediated p38 MAPK activation. and analyzed (10 µg) with the TRAF multiprobe RNase protection Since we documented TRAF6 expression at the mRNA and template set as in Fig. 1 and Methods. Dried gels were imaged by protein levels in monocytes and THP1 cells (Fig. 1) , it is could account for the difference in p38 MAPK activation between B cells and monocytic cells. It appears that in monocytic cells the CD40 receptor is not functionally linked to the p38 MAPK pathway.
Taken together, our results and the results of previous cells (35, 41) . The reason for this difference is not clear but could relate to the ERK activation being weak (35) , studies on CD40 signaling in B cells and monocytes suggest distinct differences between B cells and monocytes in CD40-differences in degree of cross-linking employed to initiate CD40 signaling, or variation in responses of different B cell dependent activation of MAPK pathways. The ERK pathway plays a primary role in CD40-dependent monocyte responses types or populations.
In the present study, the primary CD40-dependent MAPK while having minimal effects in B cells. Conversely, the JNK pathway is significantly activated in CD40-stimulated B cells pathway activated in normal peripheral blood monocytes and in the THP1 monocytic cell line was found to be the ERK1/2 but appears to play a minor role in monocytes. Similarly, a major role for CD40-activated p38 MAPK has been found in pathway. These results confirm and extend the recent findings of Suttles et al. (42) that demonstrate activation B cells but not monocytes. These cellular signaling differences may be reflected in different functional outcomes of CD40 of ERK1/2 following treatment of human monocytes with plasma membranes from PMA-and ionomycin-activated engagement. For example, although CD40 stimulation is capable of inducing B cell proliferation (2,3,7), it does not CD154 ϩ T cells. Because a membrane stimulus is not synchronous, the time courses used in the previous study for promote monocyte entry into the cell cycle. This is consistent with findings that CD40-dependent p38 MAPK activation may monocyte stimulation (10 min to 2 h) (42) were atypical for receptor-mediated MAPK activation. In contrast, our results play a role in B cell proliferation (40), but was not found to occur in monocytic cells. Additionally, the cytokine repertoire in monocytic cells directly demonstrated typical transient CD154-dependent ERK1/2 activation that was maximal within secreted by monocytes upon CD40 stimulation differs from cytokines secreted by CD40-stimulated B cells (11,45). 5-12 min after addition of the stimulus. We also mapped CD40-dependent ERK activation in normal monocytes and Accordingly, CD40-dependent ERK pathway activation appears to play a significant role in cytokine secretion by THP1 cells to link the upstream ERK1/2 activator, MEK1, to this pathway. Significant CD40-dependent activation of c-Myc human monocytes but has not been found to occur in human B cells. was found in normal monocytes, but was not apparently linked to activation of the ERK1/2 pathway. Possible links of Recent studies have compared upstream activators of MAPK pathways in B cells stimulated through either surface CD40 signaling to c-Myc phosphorylation are the JNK or NF-κB pathways.
IgM or CD40. These studies demonstrated that the same MAPK pathways can be recruited by CD40 and surface proteins activates specific downstream pathways should lead to a better understanding of how CD40 signaling events are IgM, but the two receptors use different upstream effectors (35, 41, 50, 51) . Many of the upstream effectors and links from regulated in different cell types. surface IgM to MAPK pathways have been defined (52) . Although a majority of signaling through CD40 is thought to be Acknowledgements mediated proximally through the TRAF proteins, downstream to induce high levels of TRAF1 mRNA expression (Fig. 1) . recently has been shown that fibroblasts stimulated with TNF-α or CD40-transfected fibroblasts stimulated with anti-CD40 showed high-level induction of TRAF1 mRNA (34). TRAF1 References expression also has been shown to be up-regulated in T cells following TCR engagement (53) . The role suggested for
